Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658-62)

Author: Hwi Seung KIM ¹ ; Woo Je LEE
Author Information

1. Department of Internal Medicine, Department of Internal Medicine, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, Korea
Publication Type:Response
From:Diabetes & Metabolism Journal 2022;46(4):665-666
CountryRepublic of Korea
Language:English